OpGen (OPGN) Up 40% Premarket: Why This Healthcare Stock is Surging?

2 min read | March 09, 2021 07:57 AM EST | By Shreya Biswas

OpGen (OPGN) Up 40% Premarket: Why This Healthcare Stock is Surging?

Why Are Stocks of OpGen Soaring?

OpGen describes itself as a precision medicine company that delves into the sciences of molecular diagnostics and bioinformatics. While it is located in Maryland’s Gaithersburg city in the US, it also has corporate offices in Holzgerlingen, Germany.

©Kalkine Group 2021

Early on Monday, OpGen shared its latest peer-reviewed publication which talked about a rapid diagnostic test that could help identify bacterial co-infections in hospitalized COVID-19 pneumonia patients in about five hours.

OpGen’s peer-reviewed publication said that the Unyvero Hospitalized Pneumonia (HPN) panel comes with an increased negative predictive value to detect bacterial pathogens directly from a patient’s lower respiratory tract samples.

Final results of the study found that the panel delivers a high negative predictive value of about 99.8 per cent for pathogen detection. OpGen believes that based on the latest results, Unyvero HPN panel could potentially help reduce antibiotic use.

OpGen Inc (NASDAQ:OPGN, OPGN:US) Stocks Performance

Currently priced at US$ 2.68, OpGen stocks grew about 41 per cent this year. The Maryland-based medicine company currently posts a price-to-book ratio of 4.393 and 10-day sharing trading volume averaging at nearly 41 per cent, according to TMX.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.